MedinCell

Teva, Medincell's schizophrenia drug succeeds in late-stage study
Yahoo/Reuters
Wed, 05/8/24 - 11:11 am
Teva Pharmaceutical
MedinCell
schizophrenia
clinical trials
TEV-749
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
Fierce Pharma
Mon, 05/1/23 - 10:11 pm
Teva Pharmaceutical
MedinCell
FDA
schizophrenia
Uzedy
Risperidone
Teva-partnered MedinCell bags $42M loan for long-acting injectable R&D
Fierce Pharma
Wed, 11/30/22 - 10:35 am
MedinCell
Teva Pharmaceutical
injectables
R&D
Teva receives CRL for reformulated schizophrenia drug developed with French biotech
Endpoints
Wed, 04/20/22 - 10:48 am
Teva Pharmaceutical
MedinCell
schizophrenia
FDA
complete response letter
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia
Pharmaceutical Business Review
Fri, 01/8/21 - 09:24 am
Teva Pharmaceutical
MedinCell
TV-46000
clinical trials
schizophrenia
MedinCell begins first Covid-19 clinical study with Ivermectin
Pharmaceutical Business Review
Wed, 09/30/20 - 10:32 am
MedinCell
clinical trials
COVID-19
ivermectin